CROSS HERB bought JSPR
January 2, 2026 · Form 4 insider transaction
CROSS HERB bought 90,000 shares of Jasper Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
90,000
Price
$0.00
Total value
N/A
InsiderCROSS HERB
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 5, 2026
Shares owned after90,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/4th of the shares subject to the option shall vest on January 2, 2027, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.